ResMed's Australia-listed shares hit record high on strong earnings

ResMed's Australia-listed shares RMD.AX RMD.N rise as much as 3.9% to a record high of A$44.120

Stock posts its biggest intraday pct gain since May 21

Medical device maker posts fourth-quarter profit ahead of Wall Street estimates

Says profit driven by strong demand for its devices used to manage sleep apnea

Co posts adjusted profit of $2.55 per share for the quarter ended June 30, compared with estimates of $2.48 per share

Jarden views the quarter as impressive, says "great result in our view... we expect stock to trade favourably"

Stock up nearly 3% this week, on track for a third consecutive week of gains

Stock up 19.2% this year, including the day's move